Actively Recruiting
Prophylactic Antibiotic Treatment in Hemodialysis
Led by Zealand University Hospital · Updated on 2024-01-30
800
Participants Needed
7
Research Sites
376 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to assess the efficacy of prophylactic antibiotic treatment on blood stream infections and severe culture negative infections, in patients on newly started hemodialysis(HD), with a central venous catheter as vascular access.
CONDITIONS
Official Title
Prophylactic Antibiotic Treatment in Hemodialysis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- End Stage Kidney Disease (ESKD) patients who receive an uncuffed or cuffed central venous catheter for expected chronic hemodialysis, regardless of previous treatment modality or access type
- Age 18 years or older
- Ability to understand the study, risks, and benefits and give written informed consent
You will not qualify if you...
- Unable to give informed consent
- Known intolerance to beta-lactam antibiotics and clindamycin
- Active infection currently treated with antibiotics
- Breastfeeding
- Pregnancy; women of childbearing age must use approved birth control at least 1 month before and during the 6-month treatment period
- Patients may be rescreened within one month from start of hemodialysis if exclusion criteria are reversible
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Rigshospitalet
Copenhagen, Capital Region, Denmark, 2100
Not Yet Recruiting
2
Herlev-Gentofte Hospital
Copenhagen, Capital Region, Denmark, 2730
Actively Recruiting
3
North Zealand Hospital Hillerød
Hillerød, Capital Region, Denmark, 3400
Not Yet Recruiting
4
Aarhus University Hospital
Aarhus, Middle Region, Denmark, 8200
Not Yet Recruiting
5
Aalborg University Hospital
Aalborg, North Region, Denmark, 9100
Actively Recruiting
6
ZUH Roskilde
Roskilde, Region Sjælland, Denmark, 4000
Actively Recruiting
7
Odense University Hospital
Odense, Region South, Denmark, 5000
Actively Recruiting
Research Team
N
Niels E Bruun, Professor
CONTACT
K
Kasper K Iversen, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here